Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ).
ResMed Inc., a company involved in the production and development of medical devices, particularly focusing on sleep-related respiratory care, has announced a change in the beneficial ownership by Peter C. Farrell, its Chairman Emeritus. The transaction involved the sale of 2,000 shares of ResMed common stock at a price of $242.11 per share, conducted under a pre-established Rule 10b5-1 trading plan, which may have implications on the company’s stock market position and investor sentiment.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
YTD Price Performance: 5.96%
Average Trading Volume: 910,617
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$56.47B
See more data about RMD stock on TipRanks’ Stock Analysis page.
